Mark Hyman
Co-Founder & Chief Medical Officer @ Function Health
Mark Hyman is a Series A investor at Function Health focused on Health Care and Fitness. Mark Hyman is based out of Massachusetts and is the Co-Founder and Chief Medical Officer of Function Health and also the Scientific and Medical Advisor of Klothea Bio. Mark previously worked at Canyon Ranch as a Co-Medical Director. Mark Hyman attended the University of Ottawa.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Mark Hyman invests in
Stages Mark Hyman invests in
Countries Mark Hyman invests in
Investment Focus
Industry
- Health Care 4 (80%)
- Fitness 2 (40%)
- Wellness 2 (40%)
- Medical 1 (20%)
- Payments 1 (20%)
Stage
- Series A 2 (40%)
- Seed 1 (20%)
- Funding Round 1 (20%)
- Convertible Note 1 (20%)
Country
- United States 3 (60%)
- United Kingdom 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
TrueMed is a mechanism for payments that enables health + wellness businesses to accept HSA/FSA funds. TrueMed deployments are straightforward (official Shopify payments app/code snippets) and set up in under 30 minutes without requiring any engineering on the part of the business. | $3.5M / Seed / Sep 18, 2023 | |
|
|
HumanCo is a disruptive mission-driven holding company that focuses on investing in Healthier Living.Despite all the advances in science and modern medicine, this is the first generation in recorded human history that is predicted to live a shorter lifespan than the previous generation. At HumanCo, it hopes to reverse this trend and effectmeaningful change through the companies in which we invest and incubate. | $35M / Sep 22, 2021 | |
|
|
HumanCo is a disruptive mission-driven holding company that focuses on investing in Healthier Living.Despite all the advances in science and modern medicine, this is the first generation in recorded human history that is predicted to live a shorter lifespan than the previous generation. At HumanCo, it hopes to reverse this trend and effectmeaningful change through the companies in which we invest and incubate. | $35M / Convertible Note / Sep 22, 2021 | |
|
|
A bit groggy, run-down, and over-caffeinated. Even though they were living a “healthy” lifestyle - no junk food, some exercise, and some label reading - they weren’t really thriving. So Jordan, their co-founder and corporate defector (he didn’t come from the food industry, but he’s in deep now), immersed himself in all things food: the gut-brainconnection, systemic inflammation, the impact of certain foods and additives on their health, and where potentially harmful things are hiding in their food supply. | Series A / May 15, 2018 | |
|
|
Parsley Health is a new kind of healthcare service that integrates technology, nutrition, wellness and prevention into cutting-edge primary care. The company was founded in 2016 by Dr. Robin Berzin, M.D., a Columbia-trained physician, digital health expert and leader in functional medicine. Parsley clinics are currently open in Los Angeles, NewYork City and San Francisco. Learn more at www.parsleyhealth.com | $10M / Series A / Apr 17, 2018 |
Co-Investors
About Function Health
Function Health is a health platform offering lab tests to help individuals monitor their health.
Function Health Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Daniel Sodickson
Chief Medical Scientist and Co-director
|
|||
|
Jonathan Swerdlin
Co-founder and CEO
|
|||
|
Josh Burns
VP of Finance
|
|||
|
Loren Gould
UK GM
|
|||
|
Mark Hyman
Co-Founder & Chief Medical Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Mark Hyman invest in?
Mark Hyman invests primarily in Health Care, Fitness and Wellness startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Mark Hyman last invest?
The most recent investment recorded for Mark Hyman closed in Sep 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!